Linked from

The 39 pages that link to Clostridioides difficile infection, each with the reason it gives.

• Antibiotic stewardshipRelated: Antibiotic exposure is a key modifiable risk, so safer use can prevent cases.

• VancomycinRelated: Oral vancomycin is used to treat this infection because it acts within the intestine.

• ProbioticsRelated: Probiotics have been studied for prevention, but they do not replace established treatment.

• AmoxicillinRelated: Amoxicillin exposure can raise the risk, though this complication is uncommon.

• DoxycyclineRelated: Like other antibiotics, doxycycline can disrupt gut microbes, though its associated risk is comparatively low.

• Proton pump inhibitorRelated: Reduced gastric acidity is associated with a higher infection risk, especially during antibiotic exposure.

• Hand hygieneRelated: Its hardy spores make soap-and-water washing especially relevant in care settings.

• Antibiotic therapyRelated: Antibiotics can disrupt gut microbes and increase the risk of this infection.

• MetronidazoleRelated: Metronidazole was historically used for this infection; current preferred treatments differ.

• CeftriaxoneRelated: Ceftriaxone exposure can increase the risk of this infection.

• ClindamycinRelated: Clindamycin is a prominent risk factor for this infection because it can disrupt intestinal flora.

• Fecal microbiota transplantationRelated: Recurrent infection is the treatment’s principal established indication.

• Protein synthesis inhibitorRelated: Antibiotic-driven microbiome disruption can create conditions that favor this infection.

• Penicillin allergyRelated: Alternative antibiotics used because of allergy labels may carry different risks, including this infection.

• ClostridiumRelated: A historically named clostridial pathogen causes disease through toxins and spore persistence, though it is now classified in another genus.

• Stool antigen testRelated: Some diagnostic algorithms detect C. difficile antigens alongside its toxins.

• OmeprazoleRelated: Acid suppression has been associated with increased infection risk, though the size and cause of the risk remain debated.

• CefazolinRelated: Cefazolin, like other antibiotics, can disrupt gut microbes and contribute to this infection.

• CeftazidimeRelated: Ceftazidime exposure can contribute to this potentially severe antibiotic-associated complication.

• CefiximeRelated: Cefixime use can increase the risk of this infection, as can other broad-spectrum antibiotics.

• Clavulanic acidRelated: Antibiotic treatment, including broad-spectrum combinations, can increase its risk.

• LevofloxacinRelated: Levofloxacin can disrupt gut flora and contribute to this antibiotic-associated infection.

• MoxifloxacinRelated: Moxifloxacin exposure can contribute to this potentially severe complication.

• LansoprazoleRelated: Acid suppression is associated with increased susceptibility, though an individual risk depends on clinical context.

• PantoprazoleRelated: Proton pump inhibitor use is associated with increased infection risk, though individual risk varies.

• TigecyclineRelated: Tigecycline’s broad antibacterial activity can disrupt gut microbiota and contribute to antibiotic-associated risk.

• AmpicillinRelated: Ampicillin exposure can increase the risk by disturbing protective intestinal bacteria.

• CefuroximeRelated: Cefuroxime exposure can increase risk, as with other broad-spectrum antibiotics.

• EsomeprazoleRelated: Proton-pump inhibitor exposure is associated with increased infection risk, though association does not prove causation.